ANALYSIS: As Vital Healthcare revives a restructuring scheme, directors of its external manager seem particularly antsy about their independence.
Estimates of the advantages in consolidating water services are likely to be optimistic.
The NZX-listed company makes a tough business even harder for investors.
The buyer’s financing reveals some healthy returns on offer.
The $400m government scheme has a lot of work to do.
Fletcher Building goes fuzzy with $300m.
Companies may benefit from external scrutiny, even if they pay for it.
The company’s obscure sales model has turned into a major weakness.
The co-op’s restructuring proposal is ingenious, but difficult.
Westpac’s potential NZ spin-out should be a model for others.
